Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | VIKING THERAPEUTICS INC | $3.34B | $0.00 | -$471.93M | -$472.34M | -$4.15 | N/A | N/A | N/A | N/A | 2026-07-29 | ||
| EQT | EQT CORP | $32.49B | $10.28B | $7.34B | $3.28B | $5.32 | 83.60% | 28.79% | 638.89% | N/A | 2026-07-21 | ||
| BNTX | BIONTECH SE | $21.73B | $3.30B | -$781.88M | -$1.47B | -$5.97 | 8.02% | 1.83% | N/A | N/A | |||
| SLDB | SOLID BIOSCIENCES INC | $702.93M | $0.00 | -$187.75M | -$191.78M | -$1.95 | N/A | -100.00% | N/A | N/A | |||
| PCVX | VAXCYTE INC | $6.85B | $0.00 | -$920.69M | -$946.53M | -$6.88 | N/A | N/A | N/A | N/A | 2026-08-05 | ||
| CGEM | CULLINAN THERAPEUTICS INC | $841.98M | $0.00 | -$220.73M | -$222.36M | -$3.37 | N/A | -100.00% | N/A | N/A | |||
| HIVE | HIVE DIGITAL TECHNOLOGIES LTD | $997.52M | $297.79M | $31.63M | -$147.12M | -$0.66 | 158.32% | 34.48% | N/A | N/A | 2026-06-25 | ||
| CATX | PERSPECTIVE THERAPEUTICS INC | $336.44M | $618.00k | -$107.93M | -$111.13M | -$1.40 | -57.99% | -42.25% | N/A | N/A | 2026-08-12 | ||
| ODTX | ODYSSEY THERAPEUTICS INC | N/A | $2.98M | -$144.65M | -$148.65M | -$48.93 | -33.45% | N/A | N/A | N/A | |||
| KLRA | KAILERA THERAPEUTICS INC | $2.45B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.